Real-world experience with trifluridine/tipiracil on metastatic colorectal cancer in a third level hospital

被引：0
|
作者：
Rosero Rodriguez, D. [1 ]
Perez de Aguado, P. [2 ]
Chamorro Perez, J. [1 ]
Albarran Fernandez, V. [2 ]
Longo, F. [3 ]
Reguera Puertas, P. [4 ]
Delfrade, M. [4 ]
Fuentes Mateos, R. [2 ]
Guillen-Ponce, C.
Lopez Gomez, V. [2 ]
Rodriguez Garrote, M. [4 ]
Vaz, M. [1 ]
Villamayor Delgado, M. [1 ]
Fernandez Fradejas, J. [2 ]
Garrido, P. [2 ]
Gil, M. [1 ]
Pozas, J. [3 ]
Gemeno Lopez, E. [2 ]
Sotoca Rubio, P. [2 ]
Alia Navarro, V. [2 ]
Barrill Corpa, A. [4 ]
Ferreiro Monteagudo, R. [3 ]
机构：
[1] Inst Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal, Serv Oncol Med, Madrid, Spain
[2] Hosp Univ Ramon & Cajal, Madrid, Spain
[3] Inst Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal, Madrid, Spain
[4] Hosp Univ Ramon & Cajal, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-192
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [41] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Fujimoto, Yoshiaki
    Nakanishi, Ryota
    Nukatsuka, Mamoru
    Matsuoka, Kazuaki
    Ando, Koji
    Wakasa, Takeshi
    Kitao, Hiroyuki
    Oki, Eiji
    Maehara, Yoshihiko
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1029 - 1038
  • [42] Economic Sustainability of Trifluridine/Tipiracil for the Treatment of Refractory Metastatic Colorectal Cancer in Real Life
    Giuliani, Jacopo
    Bonetti, Andrea
    CLINICAL COLORECTAL CANCER, 2020, 19 (04) : E181 - E182
  • [43] Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study
    Garcia-Alfonso, Pilar
    Munoz, Andres
    Jimenez-Castro, Jeronimo
    Jimenez-Fonseca, Paula
    Pericay, Carles
    Longo-Munoz, Federico
    Reyna-Fortes, Carmen
    Argiles-Martinez, Guillem
    Gonzalez-Astorga, Beatriz
    Jose Gomez-Reina, Maria
    Ruiz-Casado, Ana
    Rodriguez-Salas, Nuria
    Lopez-Lopez, Rafael
    Carmona-Bayonas, Alberto
    Conde-Herrero, Veronica
    Aranda, Enrique
    CANCERS, 2021, 13 (18)
  • [44] Real-world adherence and treatment discontinuation with trifluridine/tipiracil (FTD-TPI) compared with regorafenib (REG) for the treatment of metastatic colorectal cancer (mCRC).
    Patel, Anuj K.
    Duh, Mei Sheng
    Barghout, Victoria E.
    Yenikomshian, Mihran Ara
    Xiao, Yongling
    Wynant, Willy
    Tabesh, Majid
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer treatment
    Michel, Patryk S.
    Jankowski, Marek
    Sigorski, Dawid
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [46] Predictive and prognostic impact of primary tumor location on sequential treatment with regorafenib and trifluridine/tipiracil at third line and beyond in metastatic colorectal cancer: A real-world multicenter retrospective analysis
    Signorelli, C.
    Calegari, M. A.
    Basso, M.
    Anghelone, A.
    Lucchetti, J.
    Minelli, A.
    Angotti, L.
    Zurlo, I. V.
    Schirripa, M.
    Chilelli, M. G.
    Morelli, C.
    Dell'Aquila, E.
    Gemma, D.
    Ribelli, M.
    Arrivi, G.
    Zoratto, F.
    Morandi, M. G.
    Santamaria, F.
    Saltarelli, R.
    Ruggeri, E. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S442 - S443
  • [47] Real-world effectiveness and safety of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: A retrospective observational study using an administrative database.
    Shinozaki, Eiji
    Kagawa, Yoshinori
    Okude, Ryota
    Tone, Takuma
    Kunitomi, Yuji
    Nakashima, Masayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 44 - 44
  • [48] Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
    Prager, Gerald W.
    Taieb, Julien
    Fakih, Marwan
    Ciardiello, Fortunato
    Van Cutsem, Eric
    Elez, Elena
    Cruz, Felipe M.
    Wyrwicz, Lucjan
    Stroyakovskiy, Daniil
    Papai, Zsuzsanna
    Poureau, Pierre-Guillaume
    Liposits, Gabor
    Cremolini, Chiara
    Bondarenko, Igor
    Modest, Dominik P.
    Benhadji, Karim A.
    Amellal, Nadia
    Leger, Catherine
    Vidot, Loick
    Tabernero, Josep
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1657 - 1667
  • [49] Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study.
    Signorelli, Carlo
    Schirripa, Marta
    Chilelli, Mario Giovanni
    Calegari, Maria Alessandra
    Basso, Michele
    Anghelone, Annunziato
    Lucchetti, Jessica
    Minelli, Alessandro
    Angotti, Lorenzo
    Gemma, Donatello
    Dell'Aquila, Emanuela
    Cosimati, Antonella
    Arrivi, Giulia
    Morelli, Cristina
    Corsi, Domenico Cristiano
    Saltarelli, Rosa
    Morandi, Maria Grazia
    Zoratto, Federica
    Santamaria, Fiorenza
    Ruggeri, Enzo Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 45 - 45
  • [50] Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancer
    Barone, Carlo
    Di Bartolomeo, Maria
    Lonardi, Sara
    Maiello, Evaristo
    Martinelli, Erika
    Moretto, Roberto
    Strippoli, Antonia
    Tamburini, Emiliano
    Zaniboni, Alberto
    Pinto, Carmine
    FUTURE ONCOLOGY, 2021, 17 (14) : 1749 - 1759
12345